Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

Did Moderna Study Predict “Pandemic of the Vaccinated?”


10,645 views

“A new study suggests recipients of Moderna’s COVID-19 vaccine may be more likely to suffer repeated infections, perhaps indefinitely,” The Defender reported.

The study, still in preprint, found participants in Moderna’s adult trial who received the shot, and later were exposed to the virus, did not generate antibodies to a key component of the virus as often as did those in the placebo group.

The authors’ findings indicate that rates of infection are higher among vaccinated individuals.

So much for the ‘Pandemic of the Unvaccinated’ parroted by Biden, Fraudci, and the mainstream media.

In reality, it’s a ‘Pandemic of the Vaccinated.’

From The Defender:

The authors of “Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial“ wrote:

“Among participants with PCR-confirmed Covid-19 illness, seroconversion to anti-N Abs at a median follow up of 53 days post diagnosis occurred in 21/52 (40%) of the mRNA-1273 vaccine recipients vs. 605/648 (93%) of the placebo recipients (p < 0.001).”

Vaccinated participants in the trial who developed breakthrough COVID-19 — meaning they received a positive PCR test — mounted an antibody response to the nucleocapsid portion of the SARS-CoV-2 virus less often than did placebo recipients who tested positive for the virus.

The difference was statistically significant, leading the authors to conclude:

“Vaccination status should be considered when interpreting seroprevalence and seropositivity data based solely on anti-N Ab testing.

“As a marker of recent infection, anti-N Abs may have lower sensitivity in mRNA-1273-vaccinated persons who become infected.”

In other words, the authors found that using the presence of anti-nucleocapsid (anti-N) antibodies to determine whether a person was exposed to SARS-CoV-2 will miss some infections. Thus, the sensitivity of this kind of test, when applied to vaccinated individuals, is not ideal.

Igor Chudov noted these findings:

During the original Moderna Phase 3 trial, even before Delta and Omicron, scientists found the same effect: the vaccinated are much less likely to “seroconvert” and develop the above described N antibodies. The difference between the vaccinated and the unvaccinated is FIVE TIMES, which is huge. The unvaccinated are five times more likely than the vaccinated to develop broad immunity including N antibodies.

It gets even worse: for those vaccinated persons whose breakthrough infection occurred after the second dose, (illness detected on Day 29), their ability to develop N antibodies was 13 TIMES worse than that of the unvaccinated:

This inability to obtain broader natural immunity is the reason for endless covids: a covid infection in the vaccinated does not result in lasting immunity and acts similarly to an almost-worthless booster shot. A “breakthrough infection” adds a large number of temporary S-antibodies to the obsolete Wuhan virus. Whereas, the unvaccinated obtain numerous antibodies to all sorts of facets (epitopes) of the virus that infected them.

Authors also acknowledge importance of this finding and mention other studies showing the same effect:

N-Antibody Prevalence was Used for Questionable “Vaccine Effectiveness” Claims

It turns out that certain, perhaps intentionally misleading studies were using low N-antibody prevalence among the vaccinated, to falsely “prove” vaccine effectiveness. They would say “look how low is N antibody prevalence among the vaccinated!” as a proof that they do not get sick. But, as the above shows, it is not proof that they do not get sick! Sick or not, the vaccinees would NOT develop N antibodies.

What are those potentially misleading studies?

*Images from Igor Chudov*


Read the study HERE



 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Hey, Noah here!

Wondering where we went?

Read this and bookmark our new site!

See you over there!

Thanks for sharing!